The proteasome's active sites sit deep within its core, far removed from its regulatory particles, which cap the ends of the proteolytic tunnel. Nonetheless, proteasome inhibitors that bind to the core's active site, such as epoxomicin, make it more likely that the core and regulatory units coprecipitate, suggesting that inhibitors may stabilize the interface between the...
The Rockefeller University Press
2007
The Rockefeller University Press
2007
You do not currently have access to this content.